Virtu Financial’s Arcadia Biosciences RKDA Stock Holding History

Virtu Financial’s Portfolio RKDA Stock Details RKDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-11,370	Closed	-$34K	–	1983
2023 Q4	$34K	Buy	+11,370	New	+$35.6K	﹤0.01%	1236
2023 Q1	–	Sell	-328	Closed	-$4K	–	2009
2022 Q4	$4K	Buy	+328	New	+$4.67K	﹤0.01%	1458
2022 Q1	–	Sell	-515	Closed	-$21K	–	1948
2021 Q4	$21K	Buy	+515	New	+$33.6K	﹤0.01%	1512
2020 Q3	–	Sell	-749	Closed	-$113K	–	1438
2020 Q2	$113K	Buy	+749	New	+$116K	0.01%	852
2019 Q4	$61K	Buy	+277	New	+$55.6K	0.01%	1174
2019 Q3	–	Sell	-497	Closed	-$61K	–	1773
2019 Q2	$61K	Buy	497 +153	+44%	+$32.5K	﹤0.01%	1211
2019 Q1	$96K	Sell	344 -298	-46%	-$62.3K	0.01%	1134
2018 Q4	$81K	Buy	642 +24	+4%	+$4.03K	﹤0.01%	1187
2018 Q3	$121K	Buy	+618	New	+$155K	0.01%	1164
2018 Q1	–	Sell	-128	Closed	-$28K	–	2491
2017 Q4	$28K	Buy	128 +109	+574%	+$23.6K	﹤0.01%	2172
2017 Q3	$6K	Buy	+19	New	+$6.96K	﹤0.01%	2429

Other funds holding RKDA

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return

OLVIG

Oliver Lagore Vanvalin Investment Group Flint, Michigan $255M AUM

Virtu Financial's RKDA Position: Q1 2024 in Review

Virtu Financial sold out of Arcadia Biosciences (RKDA) in Q1 2024, closing a stake of 11,370 shares — an estimated $34K sold.

Virtu Financial first reported a position in RKDA in Q3 2017 and held it in 11 quarters. The position peaked at $121K in Q3 2018. 14 funds tracked by Wall St. Rank hold RKDA as of Q1 2024.

Virtu Financial reported no remaining Arcadia Biosciences position as of Q1 2024 after selling out during the quarter.
Virtu Financial sold 11,370 Arcadia Biosciences shares in Q1 2024, an estimated $34K.
Virtu Financial first reported a position in Arcadia Biosciences in Q3 2017 and held it in 11 quarters.
Virtu Financial's Arcadia Biosciences position peaked at $121K in Q3 2018.
14 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q1 2024.

Based on Virtu Financial's 13F filing for Q1 2024, filed 20 May 2024.